Oppenheimer Asset Management Inc. Teva Pharmaceutical Industries LTD Transaction History

Oppenheimer Asset Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 09, 2019	SELL	$8.12 - $15.72 $71,504 - $138,430	-8,806 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$15.58 - $20.01 $130,357 - $167,423	8,367 Added 1905.92%	8,806 $138,000
Q4 2018 Jan 30, 2019	BUY	$14.59 - $23.84 $6,405 - $10,465	439 New	439 $7,000
Q1 2018 May 09, 2018	SELL	$16.68 - $22.07 $393,114 - $520,145	-23,568 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $363,182 - $758,182	23,568	23,568 $415,000

640

580M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.